Akèy › Neuroblastom › Arkansas
Etid klinik pou Neuroblastom nan Arkansas
6 etid pou Neuroblastom ap chèche patisipan nan sit nan Arkansas.
Vil nan Arkansas
Tèks ofisyèl etid la (Anglè)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 3
Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 2
Jiska laj 22 · Tout sèks · Mizajou Sep 4, 2026 · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 1/2
Jiska laj 26 · Tout sèks · Mizajou Sep 3, 2026 · NCT06465199Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 2
Laj 1 a 21 · Tout sèks · Mizajou Sep 3, 2026 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 3
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 2
12 Months – 21 Years · Tout sèks · Mizajou Aug 12, 2026 · NCT05489887Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.